Last update 10 Dec 2024
Nanjing No. 1 Hospital

Nanjing No. 1 Hospital

Hospital|
Jiangsu Sheng, China
|
www.njsdyyy.com.cn

Overview

Tags

Neoplasms
Other Diseases
Infectious Diseases
Recombinant polypeptide

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms1
Infectious Diseases1
Top 5 Drug TypeCount
Recombinant polypeptide2
Top 5 TargetCount
GD2(Disialoganglioside GD2)1
Siglec-10(Sialic acid-binding Ig-like lectin 10)1

Related

2
Drugs associated with Nanjing No. 1 Hospital
CN117736270
Patent Mining
Target
Siglec-10
Mechanism-
Active Org.
Nanjing No. 1 HospitalNanjing No. 1 Hospital
Originator Org.
Nanjing No. 1 HospitalNanjing No. 1 Hospital
Active Indication
Infectious Diseases [+1]
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
CN116023432
Patent Mining
Target
GD2
Mechanism-
Active Org.
China Pharmaceutical UniversityChina Pharmaceutical University [+1]
Originator Org.
Nanjing No. 1 HospitalNanjing No. 1 Hospital [+1]
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Nanjing No. 1 Hospital
Login to view more data
0 Patents (Medical) associated with Nanjing No. 1 Hospital
Login to view more data
100 Deals associated with Nanjing No. 1 Hospital
Login to view more data
100 Translational Medicine associated with Nanjing No. 1 Hospital
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
CN117736270
 ( Siglec-10 )Patent Mining		Inflammation
More
Discovery
CN116023432
 ( GD2 )Patent Mining		Neoplasms
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free